跳至主要内容
临床试验/NCT00145132
NCT00145132已完成4 期

Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram

Ludwig-Maximilians - University of Munich2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
2
主要终点
changes in β-CIT/neurophysiological measurements from baseline to week 4

研究概览

简要总结

Aim of this project is to investigate the effects of escitalopram on monoamine transporter (SERT, DAT) availabilities as assessed by b-CIT and SPECT, and on neurophysiological parameters such as the loudness dependence of auditory evoked potentials (LDAEP) in patients with depression.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Psychiatric in or outpatients with acute depressive episode
  • Indication for pharmacological treatment

排除标准

  • Acute suicidality
  • Neurological or severe somatic disorders
  • Occupational exposition to radiation >15 mSv per year
  • Women during pregnancy or lactation

结局指标

主要结局

changes in β-CIT/neurophysiological measurements from baseline to week 4

时间窗: two assessments, at baseline and week 4

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验